Broadfin Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-880,303	Closed	-$4.67M	–	38
2019 Q3	$4.67M	Sell	880,303 -1,884,767	-68%	-$10M	0.86%	27
2019 Q2	$10.6M	Sell	2,765,070 -3,091,928	-53%	-$11.9M	2.31%	13
2019 Q1	$29.9M	Sell	5,856,998 -411,300	-7%	-$2.1M	6.17%	3
2018 Q4	$12M	Buy	6,268,298 +1,132,034	+22%	+$2.17M	1.58%	14
2018 Q3	$19.4M	Sell	5,136,264 -1,636,500	-24%	-$6.19M	2.86%	10
2018 Q2	$21.1M	Sell	6,772,764 -40,000	-0.6%	-$125K	3.33%	10
2018 Q1	$16.3M	Sell	6,812,764 -284,536	-4%	-$680K	2.54%	15
2017 Q4	$27.8M	Buy	7,097,300 +204,800	+3%	+$801K	4.54%	9
2017 Q3	$17.4M	Sell	6,892,500 -457,500	-6%	-$1.15M	2.57%	15
2017 Q2	$20.3M	Sell	7,350,000 -850,000	-10%	-$2.35M	2.46%	12
2017 Q1	$16M	Hold	8,200,000	–	–	1.94%	15
2016 Q4	$8.61M	Hold	8,200,000	–	–	0.96%	33
2016 Q3	$8.94M	Hold	8,200,000	–	–	0.8%	37
2016 Q2	$5.82M	Hold	8,200,000	–	–	0.57%	43
2016 Q1	$9.59M	Buy	8,200,000 +4,016,823	+96%	+$4.7M	0.93%	26
2015 Q4	$10.2M	Hold	4,183,177	–	–	0.63%	39
2015 Q3	$12.6M	Hold	4,183,177	–	–	0.7%	31
2015 Q2	$17.3M	Buy	4,183,177 +100,000	+2%	+$413K	0.93%	27
2015 Q1	$17.7M	Buy	4,083,177 +1,683,177	+70%	+$7.29M	1.38%	17
2014 Q4	$7.13M	Buy	2,400,000 +1,000,000	+71%	+$2.97M	0.62%	42
2014 Q3	$4.65M	Sell	1,400,000 -1,000,000	-42%	-$3.32M	0.49%	51
2014 Q2	$6.07M	Buy	+2,400,000	New	+$6.07M	0.59%	46